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cultures in published medical literature from Turkey in the
1997—2001 and 2002-September 2007 periods.
Method: To ﬁnd out the published series three
national databases (Ulakbim Turkish Medical Liter-
ature database, http://www.turkishmedline.com,
http://medline.pleksus.com.tr) and two international
databases (Pubmed and Science Citation Index (SCI))
were searched. Keywords for national databases were
[“idrar yolu infeksiyonu” or “idrar yolu enfeksiyonu” or
“urinary tract infection” or “u¨riner sistem infeksiyonu” or
“u¨riner sistem enfeksiyonu”]. Keywords for Index Medicus
and SCI-expanded were [“urinary tract infection” and
Turkey]. Articles i)published before 1997 ii)resistance data
of outpatient and inpatient strains were not analysed
seperately iii)antibiotic susceptibility data were not given,
were excluded. All studies used Kirby-Bauer disc diffusion
test by using NCCLS/CLSI criteria for determination of
antimicrobial resistance. Resistance data of inpatient and
outpatient strains were compared by Chi-square test. A p
value less than 0.05 was considered signiﬁcant.
Results: Data for 25577 E.coli strains were obtained from
53 articles (28 articles from 1997—2001 period, 25 from
2002—2007 period). Of these starins 18106 were isolated
from outpatients whereas 7471 from inpatients. The resis-
tance rates and comparisons of 1997—2001 and 2002—2007
periods are shown in Table 1.
Conclusions: Trimethoprim sulphametoxazole resistance
is very high and it cannot be recommended in the empiri-
cal treatment any more. Nitrofurantoin may be a cheap and
reasonable option in uncomplicated UTI. Aminoglycosides
and third-generation cephalosporins may be good choices
in the treatment of complicated UTI. Carbapenems may be
conserved for extended-spectrum beta lactamase producing
strains. ESBL rate in the outpatient strains is alarming. Poli-
cies to constrain resistance such as antibiotic stewardship
or restriction programmes should be implemented immedi-
ately.
doi:10.1016/j.ijid.2008.05.282
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Background: Acinetobacters (AC) other than A. bauman-
nii (ACOB) are occasionally recovered from clinical sources,
but OXA and MBL genes have rarely been reported. The aim
of this study was to identify and characterize OXA and MBL
genes in AC. Gene context of blaOXA-23 detected in A. radiore-
sistans (AR) was also evaluated.
Methods: AC recovered from patients in 10 countries in
the Asia-Paciﬁc (APAC) region were tested by broth microdi-
lution. Isolates with imipenem or meropenem MIC ≥8mg/L
were screened for MBL- (IMP-like, VIM-like, SIM-1, GIM-1,
SPM-1) and OXA- (OXA-23, -24, -58 clusters) genes. OXA
genes and surrounding sequences were assessed by PCR
using primers targeting to ISAba1, 2 or 3, or degenerate
primer approach. Southern blot and hybridization of chro-
mosomal and plasmid DNA were performed. RNA extraction
followed by reverse transcriptase-PCR was performed to
access expression of blaOXA-23. Species identiﬁcation was
conﬁrmed by 16S rRNA.
Results: Among 543 AC isolates, 28.2% carried OXA
(98.7%) or MBL (1.3%) genes, from which 2.6% were found
ACOB. An A. junii (AJ) with blaOXA-23 and an AR with blaOXA-23
and blaOXA-58 were detected in 2 Indian centers, while an
A. johnsonnii with blaIMP-4 and A. calcoaceticus (ACA) with
blaOXA-58 were identiﬁed in the Philippines and China, respec-
tively. ISAba1 and ISAba3 surrounded blaOXA-23 from AJ and
blaOXA-58 from AR and ACA, respectively. The AR showed a
putative O-sialoglycoprotein endopeptidase-encoding gene
upstream of blaOXA-23; gene expression was not detected;
and blaOXA-23 and blaOXA-58 were located on the chromosome
and plasmid, respectively. Susceptibility to polymyxin and
tigecycline (≤2mg/L; no breakpoint criteria) was ≥98.9%.
Conclusion: High dissemination of OXA genes was
detected, emphasizing their ability to spread among AC.
The data suggest AR may be a natural reservoir for blaOXA-23.
blaIMP-4 has been previously detected in Hong Kong, Australia
and now Philippines, highlighting spread in APAC.
doi:10.1016/j.ijid.2008.05.283
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Background: Diminishing clinical response to
ciproﬂoxacin (CIP) therapy at ICDDR, B correlated with
decreased minimum inhibitory concentration (MIC) of
V. cholerae to CIP, though strains remained susceptible
using standard thresholds. To determine the cause of the
diminished susceptibility, we investigated mutations in the
quinolone-resistance-determining-region/analogous region
of genes gyrA/B and parC/E that encode, respectively,
quinolone targets DNA gyrase and topoisomerase IV.
Method: We studied 30 clinical isolates of V. cholerae O1
and 10 of V. cholerae O139 isolated during 1993—2006. Sus-
ceptibility was determined by standard disk diffusion (DD)
and E-test methods and interpreted according to CLSI and
manufacturer’s instruction respectively. We extracted chro-
mosomal DNA, ampliﬁed and sequenced the gene fragments
and then edited, matched and aligned the sequences using
suitable methods and software to identify mutations.
Results: No mutation was detected in 9 strains having a
CIP MIC of 0.002—0.003 and a NA MIC of 0.125—0.5g/ml; a
substitution (Asparticacid87Asparagine) was noted in gyrA
was noted in 2 strains with a CIP MIC of 0.008—0.012
and a NA MIC of 4—8g/ml; a unique gyrA mutation in
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codon83 (Serine83Arginine) was noted in 1 strain having a
CIP MIC of 0.012 and a NA MIC of 32g/ml. All 28 strains
that had a CIP MIC of 0.016—1.5g/ml and frank resis-
tance to NA (MIC ≥16g/ml; DD zone of inhibition ≤13mm)
carried a transversion mutation in codon 83 of gyrA (Ser-
ine83Isoleucine). We noted another transversion mutation in
codon 85 of parC (Serine85Leucine) in 14 of these 28 strains
that had a CIP MIC of ≥0.125—1.5 and a NA MIC ≥256g/ml).
We could not detect any mutations in gyrB (n = 24) and parE
(n = 28) genes.
Conclusion: Reduced CIP-susceptibility and NA-resistance
of V. cholerae is associated with a gyrA mutation (Ser-
ine83Isoleucine). A further decrease in CIP-susceptibility is
associated with parC mutation (Serine85Leucine).
doi:10.1016/j.ijid.2008.05.284
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Background:Organisms producing extended-spectrum ˇ-
lactamases(ESBL) are emerging around the world as a source
of resistance to oxyiminocephalosporins such as cefotaxime,
ceftazidime and ceftrioxone.This study was undertaken to
study the prevalence of ESBL production by Klebsiella spp.
in an urban hospital in South India.
Methods:Antimicrobial susceptibility testing of 213
strains of Klebsiella spp. isolated from various clinical speci-
mens was carried out by disc diffusionmethod.One hundered
and ﬁve strains found to be resistant to at least one of
the third generation cepholosporins tested, viz, cefotoxime,
ceftazidime and ceftrioxone were screened for the pro-
duction of ESBL by phenotypic and genotypic methods.The
phenotypic methods include the phenotypic conﬁrmatory
disc diffusion test (PCDDT)and double disc diffusion syn-
ergy test(DDST)and the genotypic method include the PCR
ampliﬁcation method.
Results:Of the 105 strains screened for ESBL producton
45(42.85%)and 43(40.95%) strains were positive by PCDDT
and DDST methods respectively and 53(50.47%)strains were
positive by genotypic method.
Conclusion:The prevalence of ESBL produced by Kleb-
siella spp. from various clinical conditions in this part of the
country is 24.88% as detected by the genotypic method.The
study suggests that ESBL production should be detected rou-
tinely to monitor the resistant organisms for implementation
of appropriate infection control measures.
doi:10.1016/j.ijid.2008.05.285
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Background: Since ﬁrst reported in Germany in 1983
and in the United States in 1989, extended-spectrum ˇ-
lactamases (ESBLs) have spread worldwide. These enzymes
are mostly plasmid-encoded derivatives of TEM-1, TEM-2,
and SHV-1 by one or more base pair changes or are from a
rapidly evolving class called CTX-M.
Methods: K. pneumoniae ML2011 was collected on July
2004, from intensive care unit of Military hospital in Tunisia.
Identiﬁcation of strains was performed by using both API
20 E and the VITEK automated system. Minimal inhibitory
concentrations (MICs) were determined by E-test Strips
for the strain on Mueller-Hinton agar as recommended
by the Clinical and Laboratory Standards Institute (CLSI)
(CLSI/National Committee for Clinical Laboratory Stan-
dards [NCCLS], 2006). Transfer of resistance phenotypes
was performed by transformation and conjugation exper-
iments. The ESBL was identiﬁed by double-disk synergy
test, by isoelectric focusing and sequencing of PCR prod-
ucts.
Results: MICs for K. pneumoniae ML2011 showed
that this strain was resistant to all ˇ-lactams tested
expect imipenem. K. pneumoniae ML20011 exhibited a
high level of resistance to oxyimino cephalosporins.
The strain was also resistant to kanamycin, chloram-
phenicol, ciproﬂoxacin, nalidixic acid, tetracycline and
streptomycin. The disk diffusion method showed synergy
between ceftazidime, cefotaxime, aztreonam, ceftriaxon,
and amoxicillin-clavulanic acid against the strain and its
transformants and transconjugants, suggesting plasmid-
mediated production of an ESBL enzyme. PCR analyses
conﬁrmed the presence of blaSHV in parent strain K. pneu-
moniae ML2011, and its transformants E. coli DH5˛/pML2011
and transconjugants E. coli HB101 X pML2011 indicating
that this gene is located on transferable plasmid with esti-
mated molecular size of 50 kb. Nucleotide sequence was
performed on the coding region 861pb used to predict
the amino acid sequence. This sequence was compared
with strain K. pneumoniae Kp297 (DDBJ/EMBL/GeneBank
accession no. EF035567) for nucleotide sequence homol-
ogy and predicted amino sequence. Two amino acid
substitutions were found at position 5 and 202, result-
ing respectively in a Met (ATG) to Leu (TTG) and an
Arg (CGT) to Ser (AGT) changes. As theses substitu-
tions not showed by other known SHV ˇ-lactamases,
the pI 7.3 from K. pneumoniae ML2011 appears to
be a novel ESBL and has been designated SHV-104
(http://www.lahey.org).
